HbA1c goal for high risk patients in the ICU
A. <5.6%
B. 7%
C. <8%
D. 9.5%
E. 100-125
C. <8%
Normal HBA1c
A. <5.6%
B. 7%
C. <8%
D. 9.5%
E. 100-125
A. <5.6%
Target weight loss among overweight DM patients
A. <5.6%
B. 7%
C. <8%
D. 9.5%
E. 100-125
B. 7%
Level of glucose of prediabetics
A. <5.6%
B. 7%
C. <8%
D. 9.5%
E. 100-125
E. 100-125
Level of HBA1c that needs insulin injection
A. <5.6%
B. 7%
C. <8%
D. 9.5%
E. 100-125
D. 9.5%
A. Soda drink/Dextrose/glucagon
B. sulfonylureas
Secretagogues:
Sulfonyureas
Meglitides
C. Place in therapy, efficacy, hypoglycemia risk
A. Lactic Acidosis
C. 3
A. first line/ gluconeogenesis/ weight loss
D. Elderly and renal impairment
B. triggers Beta to release insulin, prevents alpha from releasing glucagon
C. triggers Beta to release insulin, prevents alpha from releasing glucagon
D. Biguanide and Sulfonylureas
B. Amylin
A. Acarbose
D. Pramlintide
B. cannot cause cancer
A. RAI
Thyroid storm medication:
Propanolol
Diltiazem
Potassium Iodide
Propylthiouracil
Hydrocortisone
C. Levothyroxine
B. Sodium iodide 131
A. PTU
B. Methimazole
B. Methimazole
A. PTU
Match the Drug with the target organ *
Biguinides: Metformin
A. Stomach
B. Pancreas
C. Muscle
D. Liver
E. Kidney
F. Intestines
D. Liver